Travere Therapeutics (TVTX) Change in Inventory (2014 - 2026)

Travere Therapeutics has reported Change in Inventory for 13 years, with the latest figure at $742000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 120.25% year-over-year to $742000.0; the trailing twelve-month figure through Mar 2026 stood at -$610000.0 (up 64.47% YoY), and the FY2025 full-year result was -$5.0 million, down 233.02% from the prior year.
• Change in Inventory for Q1 2026 stood at $742000.0, up from -$1.2 million in the prior quarter.
• The five-year high for Change in Inventory was $22.4 million in Q4 2023, with the low at -$3.7 million in Q1 2025.
• Historically, Change in Inventory has averaged $2.4 million across 5 years, with a median of $285000.0 in 2024.
• Annual changes were most pronounced in 2023 — Change in Inventory soared 59028.95% — and 2025, when it tumbled 512.98%.
• Travere Therapeutics' Change in Inventory stood at -$38000.0 in 2022, then soared by 59028.95% to $22.4 million in 2023, then plunged by 98.73% to $285000.0 in 2024, then plunged by 512.98% to -$1.2 million in 2025, then soared by 163.04% to $742000.0 in 2026.
• The last three Change in Inventory figures came in at $742000.0 (Q1 2026), -$1.2 million (Q4 2025), and -$194000.0 (Q3 2025), per Business Quant data.